Orthocell\u2019s Paul Anderson spoke with Andrew Scott at Proactive Investors about the appointment of US-based healthcare executive, Dr Ravi Thadhani, as an independent non-executive director to the Orthocell Board, and the Company\u2019s plans to draw on his expertise to drive Orthocell\u2019s Remplir\u2122 nerve product into the US market. <\/p>\n","protected":false},"excerpt":{"rendered":"
Orthocell\u2019s Paul Anderson spoke with Andrew Scott at Proactive Investors to discuss to discuss the announcement that the Company had secured\u00a0Device Technologies\u00a0as the exclusive distribution partner for Remplir\u2122 in the Australian marketplace.\u00a0<\/p>\n","protected":false},"author":2,"featured_media":4036,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3,1],"tags":[],"class_list":["post-4035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media","category-video"],"aioseo_notices":[],"_links":{"self":[{"href":"\/americas\/wp-json\/wp\/v2\/posts\/4035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/americas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/americas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/comments?post=4035"}],"version-history":[{"count":0,"href":"\/americas\/wp-json\/wp\/v2\/posts\/4035\/revisions"}],"wp:attachment":[{"href":"\/americas\/wp-json\/wp\/v2\/media?parent=4035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/categories?post=4035"},{"taxonomy":"post_tag","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/tags?post=4035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}